Calamos Advisors LLC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 65 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$26,222,000
-63.7%
14,365,000
-51.3%
0.17%
-64.1%
Q3 2014$72,236,000
-30.5%
29,516,000
-44.3%
0.48%
-26.9%
Q2 2014$103,949,000
-9.9%
52,965,000
-22.5%
0.66%
-10.6%
Q1 2014$115,311,000
+9.1%
68,318,000
-3.0%
0.74%
+9.7%
Q4 2013$105,713,000
+4.6%
70,422,000
-14.0%
0.67%
+6.0%
Q3 2013$101,055,000
+1.8%
81,844,000
-1.4%
0.63%
-2.3%
Q2 2013$99,291,00083,000,0000.65%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
GRACE BROTHERS MANAGEMENT LLC 2,800,000$5,117,0004.90%
SILVERBACK ASSET MANAGEMENT LLC 18,209,000$33,322,0004.30%
RAVEN ROCK CAPITAL MANAGEMENT, LLC 1,000,000$1,990,0002.80%
Verition Fund Management LLC 5,504,000$10,062,0002.26%
CAMDEN ASSET MANAGEMENT L P /CA 26,798,000$48,856,0001.81%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,600,000$15,679,0001.60%
TENOR CAPITAL MANAGEMENT Co., L.P. 3,000,000$5,490,0001.46%
BASSO CAPITAL MANAGEMENT, L.P. 4,825,000$8,782,0001.40%
Wellesley Asset Management 12,564$23,006,0001.35%
WOLVERINE ASSET MANAGEMENT LLC 31,156,000$56,979,0001.11%
View complete list of SALIX PHARMACEUTICALS INC shareholders